AIM
CDLX icon

Aigen Investment Management’s Cardlytics CDLX Stock Holding History

Aigen Investment Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-853
Closed -$936K – 502
2021
Q1 		$936K Sell
853
-274
-24% -$362K 0.12% 185
2020
Q4 		$1.61M Buy
+1,127
New +$1.2M 0.21% 120
2020
Q2 		– Sell
-68
Closed -$24K – 877
2020
Q1 		$24K Sell
68
-469
-87% -$332K ﹤0.01% 1078
2019
Q4 		$338K Buy
+537
New +$263K 0.06% 407

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Aigen Investment Management's CDLX Position: Q2 2021 in Review

Aigen Investment Management sold out of Cardlytics (CDLX) in Q2 2021, closing a stake of 853 shares — an estimated $936K sold.

Aigen Investment Management first reported a position in CDLX in Q4 2019 and held it in 4 quarters. The position peaked at $1.61M in Q4 2020. 189 funds tracked by Wall St. Rank hold CDLX as of Q2 2021.

  • Aigen Investment Management reported no remaining Cardlytics position as of Q2 2021 after selling out during the quarter.
  • Aigen Investment Management sold 853 Cardlytics shares in Q2 2021, an estimated $936K.
  • Aigen Investment Management first reported a position in Cardlytics in Q4 2019 and held it in 4 quarters.
  • Aigen Investment Management's Cardlytics position peaked at $1.61M in Q4 2020.
  • 189 funds tracked by Wall St. Rank held Cardlytics as of Q2 2021.

Based on Aigen Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.